Virtual Medicinal Product (VMP) - Elacestrant 345mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Elacestrant 345mg tablets | Start Date 02-09-2024 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L02BA04
- BNF Codes
-
- BNF code 08030401
| Code | Start Date | End Date |
|---|---|---|
| 43533311000001107 | 02-09-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Elacestrant dihydrochloride | Based on Base Substance | Elacestrant | 345 mg |
Name
Elacestrant dihydrochloride
Basis of strength description
Based on Base Substance
BOSS
Elacestrant
Strength and UOM (Nmr)
345.0
Strength and UOM (Dmr)
Parent Products
-
VTMElacestrant
-
VMP(Current) Elacestrant 345mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 28 tablet |